Ariad Faces Derivative Suit After Directors Cut Ties
Months after the unexpected resignation of its four independent directors, Ariad Pharmaceuticals Inc. has been hit with a derivative lawsuit by shareholders....To view the full article, register now.
Already a subscriber? Click here to view full article